Distillate Capital Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-30,486
Closed -$5.55M 146
2022
Q3
$5.55M Buy
30,486
+1,544
+5% +$316K 0.74% 77
2022
Q2
$5.83M Buy
28,942
+6,791
+31% +$1.45M 0.83% 52
2022
Q1
$5.02M Buy
22,151
+4,369
+25% +$1.03M 0.71% 79
2021
Q4
$4.8M Buy
17,782
+4,796
+37% +$1.19M 0.81% 59
2021
Q3
$3.14M Buy
12,986
+606
+5% +$153K 0.84% 55
2021
Q2
$2.93M Sell
12,380
-1,114
-8% -$254K 0.82% 61
2021
Q1
$2.96M Buy
13,494
+4,140
+44% +$831K 0.96% 31
2020
Q4
$1.62M Buy
+9,354
New +$1.62M 0.77% 68

Other funds holding LH

Distillate Capital Partners's LH Position: Q4 2022 in Review

Distillate Capital Partners sold out of Labcorp (LH) in Q4 2022, closing a stake of 30,486 shares — an estimated $5.55M sold.

Distillate Capital Partners first reported a position in LH in Q4 2020 and held it in 8 quarters. The position peaked at $5.83M in Q2 2022. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Distillate Capital Partners reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Distillate Capital Partners sold 30,486 Labcorp shares in Q4 2022, an estimated $5.55M.
  • Distillate Capital Partners first reported a position in Labcorp in Q4 2020 and held it in 8 quarters.
  • Distillate Capital Partners's Labcorp position peaked at $5.83M in Q2 2022.
  • 970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Distillate Capital Partners's 13F filing for Q4 2022, filed 15 Feb 2023.